乳腺癌中的内分泌抵抗：究竟什么才是关键？ - Suppr

Suppr

超能文献

Endocrine resistance in breast cancer: what really matters?

作者信息

Dawood S, Cristofanilli M

出版信息

Ann Oncol. 2007 Aug;18(8):1289-91. doi: 10.1093/annonc/mdm359.

DOI:10.1093/annonc/mdm359

PMID:17693644

Abstract

摘要

相似文献

Endocrine resistance in breast cancer: what really matters?

Ann Oncol. 2007 Aug;18(8):1289-91. doi: 10.1093/annonc/mdm359.

Fulvestrant in the treatment of postmenopausal women with advanced breast cancer.

Expert Rev Anticancer Ther. 2005 Jun;5(3):445-53. doi: 10.1586/14737140.5.3.445.

Adjuvant endocrine therapy in premenopausal women with breast cancer.

Breast Cancer Res Treat. 2010 Sep;123 Suppl 1:43-7. doi: 10.1007/s10549-010-1045-2. Epub 2010 Aug 14.

New approaches to reverse resistance to hormonal therapy in human breast cancer.

Drug Resist Updat. 2005 Aug;8(4):219-33. doi: 10.1016/j.drup.2005.06.002. Epub 2005 Jul 27.

Emerging strategies to overcome resistance to endocrine therapy for breast cancer.

Cancer Metastasis Rev. 2014 Sep;33(2-3):791-807. doi: 10.1007/s10555-014-9504-6.

The role of hormonal therapy in the management of hormonal-receptor-positive breast cancer with co-expression of HER2.

Nat Clin Pract Oncol. 2008 Sep;5(9):531-42. doi: 10.1038/ncponc1179. Epub 2008 Jul 8.

Hormonal modulation in the treatment of breast cancer.

Endocrinol Metab Clin North Am. 2011 Sep;40(3):519-32, viii. doi: 10.1016/j.ecl.2011.05.011.

Integration of endocrine therapy with targeted agents.

Breast Cancer Res. 2008;10 Suppl 4(Suppl 4):S20. doi: 10.1186/bcr2180. Epub 2008 Dec 18.

A new era of improving progression-free survival with dual blockade in postmenopausal HR(+), HER2(-) advanced breast cancer.

Cancer Treat Rev. 2015 Feb;41(2):94-104. doi: 10.1016/j.ctrv.2014.12.011. Epub 2014 Dec 30.

The emergence of targeted drugs in breast cancer to prevent resistance to endocrine treatment and chemotherapy.

Expert Opin Pharmacother. 2014 Apr;15(5):681-700. doi: 10.1517/14656566.2014.885952. Epub 2014 Feb 28.

引用本文的文献

U.S. FDA Drug Approvals for Breast Cancer: A Decade in Review.

Clin Cancer Res. 2022 Mar 15;28(6):1072-1086. doi: 10.1158/1078-0432.CCR-21-2600.

Prolactin induces up-regulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ERα and STAT5.

Oncotarget. 2014 Oct 15;5(19):9079-91. doi: 10.18632/oncotarget.2376.

Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes.

Breast Cancer Res. 2011 May 19;13(3):R52. doi: 10.1186/bcr2883.

The prolyl isomerase Pin1 induces LC-3 expression and mediates tamoxifen resistance in breast cancer.

J Biol Chem. 2010 Jul 30;285(31):23829-41. doi: 10.1074/jbc.M109.092874. Epub 2010 May 17.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验